Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Madrigal Pharmaceuticals Inc (YDO1.BE)

266.30
+13.30
+(5.26%)
As of 8:08:21 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
180,133
180,133
--
--
--
Cost of Revenue
6,233
6,233
--
--
--
Gross Profit
173,900
173,900
--
--
--
Operating Expense
671,775
671,775
380,496
293,571
242,482
Operating Income
-497,875
-497,875
-380,496
-293,571
-242,482
Net Non Operating Interest Income Expense
31,983
31,983
6,866
-1,779
363
Other Income Expense
--
--
--
--
273
Pretax Income
-465,892
-465,892
-373,630
-295,350
-241,846
Net Income Common Stockholders
-465,892
-465,892
-373,630
-295,350
-241,846
Diluted NI Available to Com Stockholders
-465,892
-465,892
-373,630
-295,350
-241,846
Basic EPS
-25.03
-21.90
-19.99
-17.23
-14.63
Diluted EPS
-25.03
-21.90
-19.99
-17.23
-14.63
Basic Average Shares
20,732.57
21,272.96
18,687.77
17,137.20
16,535.19
Diluted Average Shares
20,732.57
21,272.96
18,687.77
17,137.20
16,535.19
Total Operating Income as Reported
-497,875
-497,875
-380,496
-293,571
-242,482
Total Expenses
678,008
678,008
380,496
293,571
242,482
Net Income from Continuing & Discontinued Operation
-465,892
-465,892
-373,630
-295,350
-241,846
Normalized Income
-465,892
-465,892
-373,630
-295,350
-241,846
Interest Income
46,654
46,654
19,578
2,185
363
Interest Expense
14,671
14,671
12,712
3,964
--
Net Interest Income
31,983
31,983
6,866
-1,779
363
EBIT
-451,221
-451,221
-360,918
-291,386
-241,846
EBITDA
-450,125
-450,125
-360,391
-290,919
-241,441
Reconciled Cost of Revenue
6,233
6,233
--
--
--
Reconciled Depreciation
1,096
1,096
527
467
405
Net Income from Continuing Operation Net Minority Interest
-465,892
-465,892
-373,630
-295,350
-241,846
Normalized EBITDA
-450,125
-450,125
-360,391
-290,919
-241,441
12/31/2021 - 2/8/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ATQP.SG Vericel Corp
35.00
+1.16%
 
87S.DU Roivant Sciences Ltd
9.13
+2.49%
 
LT4.BE Liquidia Corp
12.07
+2.46%
 
ATQP.F Vericel Corporation
35.40
0.00%
 
A71.F Ascendis Pharma A/S
142.00
+1.43%
 
GYRE Gyre Therapeutics, Inc.
8.64
+2.86%
 
VCEL Vericel Corporation
39.42
-3.55%
 
PTCT PTC Therapeutics, Inc.
48.19
0.00%
 
ASND Ascendis Pharma A/S
159.13
-1.25%
 
RPTX Repare Therapeutics Inc.
1.3700
+14.17%